Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Pharmaceuticals Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.20 12.9% 19.25 19.05 19.25 19.35 16.80 17.20 47,769,460 16:35:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 48.3 -55.8 -34.0 - 72

Circassia Pharmaceuticals Plc Director/PDMR Shareholding

01/10/2019 11:25am

UK Regulatory (RNS & others)


Circassia Pharmaceuticals (LSE:CIR)
Historical Stock Chart

2 Months : From Sep 2019 to Nov 2019

Click Here for more Circassia Pharmaceuticals Charts.

TIDMCIR

RNS Number : 3495O

Circassia Pharmaceuticals Plc

01 October 2019

Director/PDMR Shareholding

Oxford, UK - 1 October 2019: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 30 September 2019, Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares on the London Stock Exchange at a price of 16.5 pence per share.

Contacts

 
 Circassia                                Tel: +44 (0)1865 
  Steve Harris, Chief Executive Officer    405560 
  Julien Cotta, Chief Financial Officer 
  Rob Budge, Corporate Communications 
 Peel Hunt (Nominated Adviser and Joint   Tel: +44 (0) 20 
  Broker)                                  7418 8900 
  James Steel / Dr Christopher Golden 
 finnCap (Joint Broker)                   Tel: +44 (0) 20 
  Geoff Nash / Alice Lane                  7220 0500 
 Numis Securities (Joint Broker)          Tel: +44 (0) 20 
  James Black / Freddie Barnfield          7260 1000 
 FTI Consulting                           Tel: +44 (0) 20 
  Simon Conway / Ciara Martin              3727 1000 
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
            1.   Details of the person discharging managerial responsibilities 
                  / person closely associated 
      a.         Name                             Jonathan Emms 
                ===============================  =============================== 
            2.   Reason for the notification 
                ================================================================ 
            a.   Position/status                  Chief Operating Officer 
                ===============================  =============================== 
            b.   Initial notification             Initial notification 
                  /Amendment 
                ===============================  =============================== 
            3.   Details of the issuer, emission allowance market participant, 
                  auction platform, auctioneer or auction monitor 
                ================================================================ 
            a.   Name                             Circassia Pharmaceuticals plc 
                ===============================  =============================== 
            b.   LEI                              2138006YAT138TOGA556 
                ===============================  =============================== 
            4.   Details of the transaction(s): section to be repeated for 
                  (i) each type of instrument; (ii) each type of transaction; 
                  (iii) each date; and (iv) each place where transactions 
                  have been conducted 
                ================================================================ 
            a.   Description of                   Ordinary Shares of 0.08p each 
                  the 
                  Financial instrument, 
                  type of instrument               GB00BJVD3B28 
                  Identification 
                  code 
                ===============================  =============================== 
            b.   Nature of the                    Purchase of Ordinary Shares 
                  transaction 
                ===============================  =============================== 
            c.   Price(s) and                       Price(s)   Volume(s) 
                  volume(s)                          16.5147p   300,000 
                                                               ---------- 
                ===============================  =============================== 
            d.        Aggregated information 
                        *    Aggregated volume 
                                                    n/a 
 
                        *    Price 
                ===============================  =============================== 
            e.   Date of the transaction          2019-09-30 
                ===============================  =============================== 
            f.   Place of the                     London Stock Exchange, AIM 
                  transaction 
                ===============================  =============================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBGBDGGDGBGCB

(END) Dow Jones Newswires

October 01, 2019 06:25 ET (10:25 GMT)

1 Year Circassia Pharmaceuticals Chart

1 Year Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart
Your Recent History
LSE
CIR
Circassia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191123 01:24:30